Utility of the Gold Coast criteria for amyotrophic lateral sclerosis: Experience with fast progressors.
Description:In the absence of a definitive diagnostic test for amyotrophic lateral sclerosis (ALS), various criteria have been developed by those working in the field, particularly over recent decades [1]. These criteria were typically clinically based, and described features indicative of upper and lower motor neurone disease involvement, as identified by Charcot [3]. This sustained and iterative process has culminated in consensus approaches, as promoted by the World Federation of Neurology (WFN), initially with the El Escorial criteria, later revised, and with subsequent incorporation of technological advance, particularly in the realm of clinical neurophysiology [2]. Each of these more recent criteria incorporated degrees of certainty: possible, probable or definite disease. However, a considerable proportion of patients labelled as ‘possible ALS’ ultimately succumb to the disease without ever meeting the criteria for more definitive diagnostic categories. Furthermore, these classifications often led to misunderstandings among both patients and clinicians, being mistakenly perceived as an assessment of ALS likelihood rather than a structured diagnostic framework [18]. In contrast, the most recent WFN consensus, the Gold Coast criteria, removed diagnostic uncertainty, in part to lower barriers for patient enrolment to clinical trials [16]. Now the diagnosis is ALS, or it isn't, based on the supportive information, including clinical investigations, typically used to rule out other conditions. Having established consensus criteria, it was important for validation studies, which have overwhelmingly supported a more streamlined diagnostic process, and clinical outcome [11]. In further support, a study in the current issue of Journal of Neurological Sciences has confirmed the superiority of the Gold Coast criteria when assessing ALS patients with a fast disease progression, while at the same time further validating the criteria in a further cohort of Japanese patients [13].









